Pharmacokinetics of tecovirimat in subjects with Mpox

Author:

Tempestilli Massimo,Mondi Annalisa,D'Avolio AntonioORCID,Forini Olindo,Pinnetti Carmela,Mazzotta ValentinaORCID,Gagliardini Roberta,Beccacece Alessia,De Nicolò AmedeoORCID,Faccendini Paolo,Cimini Eleonora,Maggi Fabrizio,Girardi Enrico,Nicastri Emanuele,Boffito Marta,Vaia Francesco,Antinori Andrea

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference23 articles.

1. Monkeypox treatment,2022

2. European Medicines Agency. Tecovirimat SIGA summary of product characteristics. Amsterdam: EMA. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/tecovirimat-siga [accessed 28 January 2022].

3. Oral tecovirimat for the treatment of smallpox;Grosenbach;N Engl J Med,2018

4. Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers;Chinsangaram;Antimicrob Agents Chemother,2012

5. Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjects;Jordan;Antimicrob Agents Chemother,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3